AT367038B - Verfahren zum herstellen neuer carbostyrilderivate - Google Patents

Verfahren zum herstellen neuer carbostyrilderivate

Info

Publication number
AT367038B
AT367038B AT0421378A AT421378A AT367038B AT 367038 B AT367038 B AT 367038B AT 0421378 A AT0421378 A AT 0421378A AT 421378 A AT421378 A AT 421378A AT 367038 B AT367038 B AT 367038B
Authority
AT
Austria
Prior art keywords
producing new
carbostyrile
derivatives
carbostyrile derivatives
producing
Prior art date
Application number
AT0421378A
Other languages
English (en)
Other versions
ATA421378A (de
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6931977A external-priority patent/JPS545981A/ja
Priority claimed from JP7586377A external-priority patent/JPS5412385A/ja
Priority claimed from JP53023012A external-priority patent/JPS6059912B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Priority to AT6481A priority Critical patent/AT367039B/de
Publication of ATA421378A publication Critical patent/ATA421378A/de
Application granted granted Critical
Publication of AT367038B publication Critical patent/AT367038B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT0421378A 1977-06-10 1978-06-09 Verfahren zum herstellen neuer carbostyrilderivate AT367038B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT6481A AT367039B (de) 1977-06-10 1981-01-09 Verfahren zum herstellen neuer carbostyrilderivate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6931977A JPS545981A (en) 1977-06-10 1977-06-10 Carbostyryl derivatives
JP7586377A JPS5412385A (en) 1977-06-24 1977-06-24 Carbostyril derivative
JP53023012A JPS6059912B2 (ja) 1978-02-28 1978-02-28 カルボスチリル誘導体

Publications (2)

Publication Number Publication Date
ATA421378A ATA421378A (de) 1981-10-15
AT367038B true AT367038B (de) 1982-05-25

Family

ID=27284068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0421378A AT367038B (de) 1977-06-10 1978-06-09 Verfahren zum herstellen neuer carbostyrilderivate

Country Status (21)

Country Link
US (1) US4298739A (de)
AR (2) AR224345A1 (de)
AT (1) AT367038B (de)
AU (1) AU510138B2 (de)
CA (1) CA1098907A (de)
CH (1) CH636087A5 (de)
DE (1) DE2825048A1 (de)
DK (1) DK149449C (de)
ES (2) ES470690A1 (de)
FI (1) FI69300C (de)
FR (1) FR2393795B1 (de)
GB (1) GB2002745B (de)
IE (1) IE46852B1 (de)
IT (1) IT1108326B (de)
MX (1) MX5527E (de)
NL (1) NL178074C (de)
NO (1) NO148813C (de)
NZ (1) NZ187452A (de)
PH (1) PH14670A (de)
PT (1) PT68157A (de)
SE (1) SE444562B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
AT383594B (de) * 1980-02-29 1987-07-27 Otsuka Pharma Co Ltd Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
DK69285A (da) * 1984-02-15 1985-08-16 Syntex Inc Tetrahydroimidazolderivater
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
TW201305B (de) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
US5506239A (en) * 1991-08-23 1996-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative and platelets aggregation inhibitory agent
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2527360B1 (de) 2007-06-04 2015-10-28 Synergy Pharmaceuticals Inc. Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
AU2009256157B2 (en) 2008-06-04 2014-12-18 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
JP2011528375A (ja) 2008-07-16 2011-11-17 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2196453A1 (de) * 2008-12-10 2010-06-16 Cellvir Neuartige substituierte Aryl-Derivate, Herstellungsverfahren dafür und ihre therapeutische Verwendungen als anti-HIV-Mittel
WO2011021676A1 (ja) 2009-08-21 2011-02-24 大塚製薬株式会社 ベンゾ[b][1,4]ジアゼピン-2,4-ジオン化合物の製造方法
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
EP2804603A1 (de) 2012-01-10 2014-11-26 President and Fellows of Harvard College Betazellen-replikation für promoterverbindungen und verwendungsverfahren dafür
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
EP4424697A2 (de) 2013-06-05 2024-09-04 Bausch Health Ireland Limited Ultrareine agonisten der guanylatcyclase c, verfahren zur herstellung und verwendung davon
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
EP3972599A1 (de) 2019-05-21 2022-03-30 Ardelyx, Inc. Kombination zur senkung des serum-phosphatspiegels bei einem patienten

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (de) * 1972-12-14 1977-10-03
JPS5234629B2 (de) * 1973-02-03 1977-09-05
SE431451B (sv) * 1973-10-24 1984-02-06 Otsuka Pharma Co Ltd Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
US4070470A (en) * 1974-06-24 1978-01-24 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting carbostyrils, their compositions and method of use
JPS54119478A (en) * 1978-03-06 1979-09-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Also Published As

Publication number Publication date
DE2825048C2 (de) 1991-05-08
GB2002745A (en) 1979-02-28
IT1108326B (it) 1985-12-09
FI69300B (fi) 1985-09-30
DK149449C (da) 1986-11-24
NO782022L (no) 1978-12-12
CA1098907A (en) 1981-04-07
CH636087A5 (de) 1983-05-13
NO148813C (no) 1983-12-21
AU3686678A (en) 1979-12-13
PH14670A (en) 1981-10-30
MX5527E (es) 1983-09-23
IE781104L (en) 1978-12-10
US4298739A (en) 1981-11-03
AR225755A1 (es) 1982-04-30
GB2002745B (en) 1982-02-17
AU510138B2 (en) 1980-06-12
ES470690A1 (es) 1979-10-16
IE46852B1 (en) 1983-10-05
PT68157A (en) 1978-07-01
FI69300C (fi) 1986-01-10
FI781811A (fi) 1978-12-11
SE7806710L (sv) 1978-12-11
SE444562B (sv) 1986-04-21
ES479138A1 (es) 1979-07-01
FR2393795A1 (fr) 1979-01-05
NL178074C (nl) 1986-01-16
DK149449B (da) 1986-06-16
NZ187452A (en) 1980-05-27
ATA421378A (de) 1981-10-15
NO148813B (no) 1983-09-12
DK254878A (da) 1979-02-09
IT7868355A0 (it) 1978-06-09
FR2393795B1 (fr) 1986-07-25
AR224345A1 (es) 1981-11-30
NL7806245A (nl) 1978-12-12
DE2825048A1 (de) 1978-12-14

Similar Documents

Publication Publication Date Title
AT367038B (de) Verfahren zum herstellen neuer carbostyrilderivate
AT364363B (de) Verfahren zum herstellen neuer tetrazolylalkoxycarbostyrilderivate
DD134528A5 (de) Verfahren zum herstellen von schwefelhaltigen organosiliciumverbindungen
AT379345B (de) Verfahren zum herstellen von gipsplatten
AT359640B (de) Verfahren zum herstellen eines gammaglobulin- praeparates
AT375784B (de) Verfahren zum erzeugen magnetisierter bereiche
DD132129A5 (de) Verfahren zum herstellen von cellulosealkylaethern
AT376418B (de) Verrahren zum herstellen neuer phenylaethylaminderivate
ATA612278A (de) Verfahren zum herstellen von rollgebaeck
AT355101B (de) Verfahren zum herstellen eines leuchtschirmes
AT361921B (de) Verfahren zum herstellen von neuen chromen- derivaten
AT359491B (de) Verfahren zum herstellen neuer benzamidin- derivate
AT379547B (de) Verfahren zum herstellen von hohlkoerpern
AT359088B (de) Verfahren zum herstellen von auranofin
AT370535B (de) Verfahren zum herstellen eines originals
AT373591B (de) Verfahren zum herstellen neuer 1,3-benzoxazin-2,4-dion-derivate
AT362797B (de) Verfahren zum herstellen von auranofin
AT367039B (de) Verfahren zum herstellen neuer carbostyrilderivate
AT370709B (de) Verfahren zum herstellen eines neutronensicheren betons
ATA8080A (de) Verfahren zum herstellen neuer benzamidin- derivate
AT353564B (de) Verfahren zum herstellen eines feststoffge- misches
ATA394377A (de) Verfahren zum herstellen eines durchlassbau- werkes
ATA364578A (de) Verfahren zum herstellen von olefinpoly- merisaten
ATA102880A (de) Verfahren zum herstellen eines kaeseartiger konsistenz
ATA784179A (de) Verfahren zum herstellen neuer chlorierter diraccheride

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee